℞ Prescription medicines · Flat US$ 25 shipping up to 1 kg · Ask first on WhatsApp
RK PharmaPrescription medicines from India, shipped worldwide

Medicine guide · Updated 2026-11-19

Osimertinib: Uses, Dosage, Side Effects, Monitoring and Price of Generic Osimertinib from India

RK Pharma editorial team · Sources listed at the end

In brief

  • Osimertinib is an EGFR kinase inhibitor approved for non-small cell lung cancer (NSCLC) with EGFR exon 19 deletions or exon 21 L858R mutations, and for T790M-positive disease after an earlier EGFR inhibitor; a validated mutation test comes first.
  • The US label's usual dose is 80 mg once a day with or without food: for 3 years after surgery, otherwise until the cancer progresses or side effects are too severe. Your oncologist decides your dose.
  • Key safety checks on the label: lung inflammation (ILD/pneumonitis), QT prolongation on the ECG, heart function, eye and skin problems; avoid strong CYP3A inducers and, in the EU, St John's wort.
  • Generic osimertinib from India costs approximately US$ 34-114 per 10 tablets (Indian MRP of generic brands; exact quote on WhatsApp).
  • RK Pharma in Surat supplies osimertinib 40 mg and 80 mg against a valid prescription, with flat US$ 25 shipping for parcels up to 1 kg.

Osimertinib is an oral targeted cancer medicine, a third-generation EGFR tyrosine kinase inhibitor, used for non-small cell lung cancer (NSCLC) whose tumour carries an EGFR mutation. It is sold as Tagrisso in the US and Europe, and generic versions are made in India. Treatment often lasts years, so the price matters: generic osimertinib is available from RK Pharma at approximately US$ 34-114 per 10 tablets, supplied only against a valid prescription from your oncologist. This guide summarises what the US label (updated September 2026) and the European Medicines Agency say about uses, dosing, monitoring and side effects, and how ordering from India works.

What is osimertinib used for?

Osimertinib is only for lung cancers with specific EGFR mutations, confirmed by a test. The US label lists these uses:

Use (US label) EGFR mutation Treatment
After complete surgical removal of the tumour (adjuvant) Exon 19 deletion or exon 21 L858R Alone, for up to 3 years
Unresectable stage III NSCLC that has not progressed after platinum chemoradiation Exon 19 deletion or exon 21 L858R Alone
First treatment of metastatic NSCLC Exon 19 deletion or exon 21 L858R Alone
First treatment of locally advanced or metastatic NSCLC Exon 19 deletion or exon 21 L858R With pemetrexed and platinum chemotherapy
Metastatic NSCLC after an earlier EGFR inhibitor T790M Alone

The label says patients are selected with an FDA-approved test: on tumour tissue for the adjuvant and stage III uses, and on tumour or plasma (a blood test) for first-line and T790M use. The European Medicines Agency's overview lists the same five uses in the EU and says a genetic test must confirm the mutation before treatment starts.

How does osimertinib work?

EGFR (epidermal growth factor receptor) is a protein on cell surfaces that tells cells to grow. In some lung cancers a mutation leaves EGFR switched on, driving the cancer. Osimertinib blocks the mutated receptor, including the T790M form that commonly causes resistance to older EGFR inhibitors such as gefitinib, erlotinib and afatinib. Because it acts on a specific mutation, it does not help lung cancers without one, which is why testing comes first.

How is osimertinib taken?

The label's usual dose is below. It is for information only: your oncologist decides your dose.

Situation (US label) Usual dose
All approved uses 80 mg once a day, with or without food
After surgery (adjuvant) For 3 years in total, or until recurrence or unacceptable toxicity
Other uses Until disease progression or unacceptable toxicity
QTc over 500 ms on at least 2 ECGs Withhold until QTc is below 481 ms, then restart at 40 mg
Other grade 3 or higher side effects Withhold up to 3 weeks, then restart at 80 mg or 40 mg if improved
Strong CYP3A inducer that cannot be avoided 160 mg a day; back to 80 mg 3 weeks after the inducer stops

Practical points from the label:

  • Missed dose: do not make it up; take the next dose at the usual time.
  • Swallowing problems: disperse the tablet in 60 mL of non-carbonated water only and drink it straight away; it can also go through a nasogastric tube. Do not crush, heat or ultrasonicate it.
  • Take it at about the same time each day.

What are the side effects of osimertinib?

With osimertinib alone, the label's most common side effects (20% or more of patients) are diarrhoea (47%), rash (46%), musculoskeletal pain (38%), nail toxicity (34%), dry skin (32%), stomatitis or mouth sores (24%) and fatigue (21%). Common laboratory changes include lower white cells, lymphocytes, platelets and red cells. The EMA overview names diarrhoea, rash, paronychia (nail-fold infection), dry skin and stomatitis as affecting more than 1 in 5 people.

Serious warnings on the label:

Warning Label figure What it means for you
Interstitial lung disease / pneumonitis 4% with osimertinib alone (0.4% fatal) Report new or worse cough, breathlessness or fever at once
QTc prolongation QTc over 500 ms in 1.1% (alone) ECGs and salt (electrolyte) checks if you have heart risks
Cardiomyopathy 3.8% alone; 9% with chemotherapy Heart scans if you have heart risk factors
Keratitis 0.6% Report eye pain, redness or blurred vision promptly
Erythema multiforme, Stevens-Johnson syndrome, TEN Rare Stop and seek care for blistering or peeling skin
Cutaneous vasculitis Rare Report new purple or red skin spots
Aplastic anaemia 0.06% Blood counts; report infections, bleeding or tiredness
Muscle pain or myositis with raised CPK Added to the label in 2026 Report unexplained muscle pain or weakness
Harm to an unborn baby n/a Effective contraception (see below)

Who should be careful, and what are the interactions?

  • Strong CYP3A inducers (for example rifampicin, carbamazepine and phenytoin) lower osimertinib levels; the label says to avoid them, or to increase the dose to 160 mg if they cannot be avoided.
  • St John's wort must not be used with osimertinib, according to the EMA overview.
  • QT-prolonging medicines, heart failure, congenital long QT syndrome or electrolyte problems need extra ECG monitoring.
  • Pregnancy: the label advises effective contraception during treatment and for 6 weeks after the last dose for women, and for 4 months after the last dose for men with female partners who could become pregnant.
  • Breathing problems: tell the team about any existing lung disease, and about recent chest radiotherapy; ILD was much more frequent in the LAURA trial after chemoradiation.

Give your oncologist and pharmacist a full list of other medicines, supplements and herbal products.

What should you tell your oncologist before starting osimertinib?

The label's warnings show what the treating team needs to know before the first tablet. Mention:

  • any lung disease, previous pneumonitis or recent chest radiotherapy;
  • heart problems: heart failure, a slow or irregular heartbeat, a long QT interval, or medicines known to prolong QT;
  • low potassium or magnesium, or conditions that cause them, such as long-lasting diarrhoea or diuretics;
  • eye problems, contact-lens use or dry eyes;
  • past severe skin reactions to any medicine;
  • pregnancy, plans for pregnancy or breastfeeding, and the contraception you use;
  • every other medicine, supplement and herbal product, including St John's wort;
  • the result and type of your EGFR test (tissue or blood), which your oncologist uses to confirm the indication.

The European Medicines Agency's page for Tagrisso (updated September 2026) confirms it is authorised in the EU for EGFR-mutated non-small cell lung cancer and is started and supervised by a doctor experienced in cancer medicines.

What monitoring does osimertinib need?

Monitoring follows the label's warnings and your oncologist's plan. It usually includes:

  • Scans at intervals set by the oncologist to check the response.
  • Blood counts, because low white cells, platelets and red cells are common.
  • ECG and electrolytes (potassium, magnesium) in people with heart risks or QT-prolonging medicines.
  • Heart function (echocardiogram) in people with cardiac risk factors.
  • Eye and skin review when symptoms appear.
  • Breathing symptoms at every visit.

Keep copies of every result with your prescription. If you buy osimertinib abroad, your local oncologist still needs to see them.

How much does osimertinib cost from India?

RK Pharma's approximate price for generic osimertinib is US$ 34-114 per 10 tablets, based on the Indian MRP of generic brands; the exact price depends on strength and brand and is confirmed on WhatsApp. Shipping is a flat US$ 25 for parcels up to 1 kg.

Product (RK Pharma) Strengths Approximate price Use (label)
Osimertinib 40 mg, 80 mg tablets US$ 34-114 per 10 tablets EGFR-mutated NSCLC, incl. T790M
Gefitinib 250 mg tablets US$ 23-74 per 30 tablets EGFR-mutated NSCLC
Erlotinib 100 mg, 150 mg tablets US$ 34-102 per 30 tablets EGFR-mutated NSCLC
Afatinib 20, 30, 40 mg tablets US$ 45-136 per 28 tablets EGFR-mutated NSCLC

All prices are approximate, based on Indian MRP of generic brands; exact quote on WhatsApp. Which EGFR inhibitor is used, and in what order, is always the oncologist's decision. See all oncology medicines.

Is generic osimertinib from India the same as Tagrisso?

Generic osimertinib contains the same active substance, osimertinib (as the mesylate salt), in the same 40 mg and 80 mg strengths as Tagrisso. Indian generics are approved for sale in India. Whether you may import one for personal use depends on your country's law. We name the brand and manufacturer before you order so your oncologist can review it, and packs are shipped sealed with their leaflet; check the strength, batch number and expiry date on arrival.

Can osimertinib be shipped to the UK or Australia?

Personal-import rules differ by country and change over time, and we never promise customs clearance. Check your country page first:

Our guide to personal import of prescription medicines from India explains the usual documents: the prescription, the invoice and, for long-term treatment, a doctor's letter.

Worked example: a 3-month supply to Australia

A patient in Australia with exon 19-deleted metastatic NSCLC has a prescription for osimertinib 80 mg once a day. Three months is about 90 tablets.

Step What happens
1. Ask The family messages RK Pharma on WhatsApp: "Osimertinib 80 mg, 90 tablets, Australia"
2. Quote We confirm the brand and the approximate price: 9 packs of 10 at US$ 34-114 each (about US$ 306-1,026 in total), plus US$ 25 shipping if the parcel is under 1 kg
3. Prescription They share the oncologist's prescription in the chat; nothing is dispatched until it is checked
4. Import rules They read the Australia page and keep the prescription and invoice with the parcel
5. Treatment The patient keeps the scan, blood and ECG schedule set by the oncologist

If the oncologist reduces the dose to 40 mg after a side effect, the family sends the new prescription and we quote again for the 40 mg strength.

How do you buy osimertinib from RK Pharma?

You can buy osimertinib from RK Pharma in Surat, India, with a valid prescription:

  1. Open the osimertinib product page or read how to order.
  2. Message us on WhatsApp (+91 72111 55537) with the strength, quantity and country. Ask questions first if you need to.
  3. Share the prescription privately in the chat; nothing is dispatched until it has been checked.
  4. Pay as agreed and receive tracking.

You can also reach us through the contact page. Our imatinib guide explains how long-term oral cancer treatment is ordered in the same way. We do not give medical advice; your oncologist decides whether osimertinib is right for you, at what dose and for how long.

Can you buy Osimertinib from RK Pharma?

Yes. You can buy Osimertinib from RK Pharma in Surat, India. We supply it against a valid prescription and ship it in sealed original packs, with a flat US$ 25 shipping charge for parcels up to 1 kg. Message us on WhatsApp first with no prescription needed to ask: we confirm the brand, strength, price and your country's import rules, and you share your prescription privately in the same chat before we dispatch.

  See Osimertinib price and details →

Frequently asked questions

What is osimertinib used for?

Osimertinib treats non-small cell lung cancer with certain EGFR mutations: after surgery (adjuvant), after chemoradiation for unresectable stage III disease, as first treatment for advanced disease alone or with pemetrexed and platinum chemotherapy, and for T790M-positive cancer after an earlier EGFR inhibitor, according to the US label and the EMA.

What is the usual dose of osimertinib?

The US label's usual dose is 80 mg by mouth once a day, with or without food. It is reduced to 40 mg after some side effects and raised to 160 mg if a strong CYP3A inducer cannot be avoided. Your oncologist decides your dose and how long you take it.

How long do you take osimertinib?

After complete surgical removal of the tumour, the label sets a total of 3 years or until recurrence or unacceptable side effects. In the other approved uses, treatment continues until the disease progresses or side effects become unacceptable. Your oncologist reviews this at every scan.

What are the most common side effects of osimertinib?

With osimertinib alone the label lists diarrhoea (47%), rash (46%), musculoskeletal pain (38%), nail changes (34%), dry skin (32%), mouth sores (24%) and fatigue (21%). Lower blood counts are also common on laboratory tests. Most are managed with supportive care or a dose pause.

What serious problems can osimertinib cause?

The label warns about lung inflammation (interstitial lung disease, about 4% with osimertinib alone), QT prolongation, heart muscle weakness, keratitis, severe skin reactions, cutaneous vasculitis, aplastic anaemia and harm to an unborn baby. New breathlessness or cough needs urgent medical review.

Can osimertinib be taken if you cannot swallow tablets?

Yes, according to the US label. The tablet can be dispersed in 60 mL (2 ounces) of non-carbonated water only, and it can be given through a nasogastric tube. It should not be crushed, heated or ultrasonicated. Ask your pharmacist to show you the method.

How much does generic osimertinib cost from India?

At RK Pharma, generic osimertinib costs approximately US$ 34-114 per 10 tablets, based on the Indian MRP of generic brands. A month at 80 mg a day is three packs of 10. Shipping is a flat US$ 25 for parcels up to 1 kg; ask on WhatsApp for an exact quote.

Who supplies osimertinib from India?

RK Pharma in Surat, India supplies Osimertinib against a valid prescription; ask questions first on WhatsApp +91 72111 55537. We confirm the strength, brand, approximate price and your country's import rules before you order.

Sources

  1. DailyMed: TAGRISSO (osimertinib) tablets, US prescribing information (updated September 2026)
  2. European Medicines Agency: Tagrisso EPAR medicine overview (12/2024)
  3. European Medicines Agency: Tagrisso EPAR page (updated 10/09/2026)

This page gives general product information and is not medical advice. Take this medicine only as prescribed and supervised by your own doctor.

Flat US$ 25 for a small parcel up to 1 kg, with tracking.